Edina Cenko: Looking Beyond the Epicardial Coronary Arteries
Edina Cenko, Chairperson of ESC Working Group on Coronary Pathophysiology and Microcirculation, posted on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Cardiology, adding:
“For decades, ischemic heart disease has been viewed mainly through the lens of epicardial coronary arteries.
However, growing evidence shows that the coronary microcirculation is a key determinant of symptoms, prognosis, and outcomes.
Why does this matter in clinical practice?
Patients with INOCA, and many patients after acute coronary syndromes, may have significant CMD that remains undetected if we focus only on angiography.
Identifying CMD can improve risk stratification and support more personalized management.
This systematic review and meta-analysis of 31 studies including more than 13,000 patients showed that invasively diagnosed CMD is associated with:
- 2.5-fold higher risk of MACE
- Nearly 3-fold higher risk of cardiovascular mortality
- Increased risk of myocardial infarction, heart failure hospitalization, and stroke
Patients with structural CMD (abnormal CFR and IMR) showed the highest risk, highlighting the importance of phenotyping CMD rather than considering it a single condition.
The message is clear: to fully understand ischemic heart disease, we must look beyond the epicardial arteries and consider the entire coronary circulation.
Congratulations to Konstantinos Kyriakoulis and the entire team for this important contribution to the field of coronary microvascular disease.”
Title: Prognostic effect of invasively diagnosed coronary microvascular dysfunction: A systematic review and META-analysis
Authors: Konstantinos G. Kyriakoulis, Kyriakos Dimitriadis, Athanasios Sakalidis, Nikolaos Pyrpyris, Eleni Adamopoulou, Stergios Soulaidopoulos, Panagiotis Tsioufis, Ioannis Doundoulakis, Angelos Papanikolaou, Konstantinos Aznaouridis, Petros Galanis, Natalija R. Odanovic, Ivan Ilic, Elmir Omerovic, Edina Cenko, Konstantinos Tsioufis

Stay updated with Hemostasis Today.
-
Aug 12, 2026, 03:10Ageing with Haemophilia – A Changing Clinical Landscape – EAHAD
-
Aug 12, 2026, 02:23Marco Vitolo: The Odyssey of Stroke Prevention in ESRD and AF
-
Aug 12, 2026, 02:05Kellie Machlus: Postdoc Opening in Translational Hematology at BCH/HMS
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal